1. Home
  2. FIVE vs GH Comparison

FIVE vs GH Comparison

Compare FIVE & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Five Below Inc.

FIVE

Five Below Inc.

HOLD

Current Price

$217.35

Market Cap

13.0B

ML Signal

HOLD

Logo Guardant Health Inc.

GH

Guardant Health Inc.

HOLD

Current Price

$78.81

Market Cap

13.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FIVE
GH
Founded
2002
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Department/Specialty Retail Stores
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.0B
13.3B
IPO Year
2012
2018

Fundamental Metrics

Financial Performance
Metric
FIVE
GH
Price
$217.35
$78.81
Analyst Decision
Buy
Strong Buy
Analyst Count
21
19
Target Price
$225.95
$120.05
AVG Volume (30 Days)
1.2M
1.7M
Earning Date
03-18-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
40.65
6.74
EPS
6.47
N/A
Revenue
$4,764,147,000.00
$982,021,000.00
Revenue This Year
$14.40
$33.30
Revenue Next Year
$9.41
$28.19
P/E Ratio
$34.78
N/A
Revenue Growth
22.90
32.88
52 Week Low
$60.81
$36.36
52 Week High
$238.40
$120.74

Technical Indicators

Market Signals
Indicator
FIVE
GH
Relative Strength Index (RSI) 44.98 35.40
Support Level $208.50 $54.39
Resistance Level $233.42 $114.53
Average True Range (ATR) 8.87 5.45
MACD -1.40 0.07
Stochastic Oscillator 17.86 16.18

Price Performance

Historical Comparison
FIVE
GH

About FIVE Five Below Inc.

Five Below Inc is a specialty value retailer offering a broad range of trend-right, high-quality products loved by the kid and the kid in all of customers. The Company's edited assortment of products includes select brands and licensed merchandise. The Company also sells its merchandise on the internet, through the Company's e-commerce website and mobile app, offering home delivery and the option to buy online and pick up in store. Additionally, the Company sells merchandise through on-demand third-party delivery services to enable its customers to shop online and receive convenient delivery. It derives revenue from sales of the Company's merchandise to customers.

About GH Guardant Health Inc.

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

Share on Social Networks: